Cite

HARVARD Citation

    Rizzardini, G. et al. (2020). Long-Acting Injectable Cabotegravir + Rilpivirine for HIV Maintenance Therapy. Journal of acquired immune deficiency syndromes. p. . [Online]. 
  
Back to record